Literature DB >> 20382242

Echinacea purpurea aerial extract alters course of influenza infection in mice.

Dahlene Fusco1, Xinyan Liu, Caroline Savage, Ying Taur, Weilie Xiao, Edward Kennelly, Jianda Yuan, Barrie Cassileth, Mirella Salvatore, Genovefa A Papanicolaou.   

Abstract

Influenza infection is a major clinical problem and Echinacea purpurea, a widely consumed botanical product, is purported to alter the course of respiratory infections including influenza. Mice infected with WSN influenza A and treated with E. purpurea polysaccharide extract had less weight loss than untreated mice but similar pulmonary viral titers. Echinacea-treated mice had lower systemic and pulmonary KC and IL-10 levels and lower systemic IFN-gamma levels following influenza infection. These suggest that E. purpurea alters the clinical course of influenza infection in mice through modulation of cytokines and not direct antiviral activity. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382242      PMCID: PMC3016056          DOI: 10.1016/j.vaccine.2010.03.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Update: influenza activity - United States, September 28, 2008--January 31, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-02-13       Impact factor: 17.586

2.  Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.

Authors:  D B Mendel; C Y Tai; P A Escarpe; W Li; R W Sidwell; J H Huffman; C Sweet; K J Jakeman; J Merson; S A Lacy; W Lew; M A Williams; L Zhang; M S Chen; N Bischofberger; C U Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin.

Authors:  K Tobita; A Sugiura; C Enomote; M Furuyama
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

4.  Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism.

Authors:  Melanie J Scott; Shubing Liu; Richard A Shapiro; Yoram Vodovotz; Timothy R Billiar
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Virology       Date:  2009-06-02       Impact factor: 3.616

6.  IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge.

Authors:  K Kai McKinstry; Tara M Strutt; Amanda Buck; Jonathan D Curtis; John P Dibble; Gail Huston; Michael Tighe; Hiromasa Hamada; Stewart Sell; Richard W Dutton; Susan L Swain
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

8.  Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Authors:  Rebecca J Garten; C Todd Davis; Colin A Russell; Bo Shu; Stephen Lindstrom; Amanda Balish; Wendy M Sessions; Xiyan Xu; Eugene Skepner; Varough Deyde; Margaret Okomo-Adhiambo; Larisa Gubareva; John Barnes; Catherine B Smith; Shannon L Emery; Michael J Hillman; Pierre Rivailler; James Smagala; Miranda de Graaf; David F Burke; Ron A M Fouchier; Claudia Pappas; Celia M Alpuche-Aranda; Hugo López-Gatell; Hiram Olivera; Irma López; Christopher A Myers; Dennis Faix; Patrick J Blair; Cindy Yu; Kimberly M Keene; P David Dotson; David Boxrud; Anthony R Sambol; Syed H Abid; Kirsten St George; Tammy Bannerman; Amanda L Moore; David J Stringer; Patricia Blevins; Gail J Demmler-Harrison; Michele Ginsberg; Paula Kriner; Steve Waterman; Sandra Smole; Hugo F Guevara; Edward A Belongia; Patricia A Clark; Sara T Beatrice; Ruben Donis; Jacqueline Katz; Lyn Finelli; Carolyn B Bridges; Michael Shaw; Daniel B Jernigan; Timothy M Uyeki; Derek J Smith; Alexander I Klimov; Nancy J Cox
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).

Authors:  Stephan Pleschka; Michael Stein; Roland Schoop; James B Hudson
Journal:  Virol J       Date:  2009-11-13       Impact factor: 4.099

10.  Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection.

Authors:  M B Graham; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  15 in total

1.  Determination of major phenolic compounds in Echinacea spp. raw materials and finished products by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation matrix extension.

Authors:  Paula N Brown; Michael Chan; Lori Paley; Joseph M Betz
Journal:  J AOAC Int       Date:  2011 Sep-Oct       Impact factor: 1.913

2.  Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii.

Authors:  Arquimedes Gasparotto Junior; Maria Luiza Antonio Cosmo; Michelle de Paula Reis; Pamela Secundo Dos Santos; Daniela Dib Gonçalves; Francielly Mourão Gasparotto; Italmar Teodorico Navarro; Emerson Luiz Botelho Lourenço
Journal:  Parasitol Res       Date:  2016-06-09       Impact factor: 2.289

Review 3.  Newer influenza antivirals, biotherapeutics and combinations.

Authors:  Frederick G Hayden
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

4.  Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.

Authors:  Travis V Gulledge; Nicholas M Collette; Emily Mackey; Stephanie E Johnstone; Yasamin Moazami; Daniel A Todd; Adam J Moeser; Joshua G Pierce; Nadja B Cech; Scott M Laster
Journal:  J Ethnopharmacol       Date:  2017-10-14       Impact factor: 4.360

5.  Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.

Authors:  Fabiana N Fonseca; Genovefa Papanicolaou; Hong Lin; Clara B S Lau; Edward J Kennelly; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Int Immunopharmacol       Date:  2014-01-13       Impact factor: 4.932

Review 6.  Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.

Authors:  James B Hudson
Journal:  J Biomed Biotechnol       Date:  2011-10-26

Review 7.  Echinacea purpurea: Pharmacology, phytochemistry and analysis methods.

Authors:  Azadeh Manayi; Mahdi Vazirian; Soodabeh Saeidnia
Journal:  Pharmacogn Rev       Date:  2015 Jan-Jun

Review 8.  Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1.

Authors:  E M Abdelwhab; Hafez M Hafez
Journal:  Viruses       Date:  2012-11-19       Impact factor: 5.048

9.  Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.

Authors:  Xinyan Liu; Yaling He; Kun Xiao; Julie R White; Dahlene N Fusco; Genovefa A Papanicolaou
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

Review 10.  Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review.

Authors:  Hannah Ayrle; Meike Mevissen; Martin Kaske; Heiko Nathues; Niels Gruetzner; Matthias Melzig; Michael Walkenhorst
Journal:  BMC Vet Res       Date:  2016-06-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.